Jupiter Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Jupiter Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2.32M	Sell	48,442 -35,275	-42%	-$1.76M	0.04%	238
2020 Q1	$3.85M	Sell	83,717 -6,407	-7%	-$322K	0.08%	170
2019 Q4	$5.41M	Hold	90,124	–	–	0.08%	218
2019 Q3	$5.1M	Buy	90,124 +33,027	+58%	+$1.86M	0.07%	237
2019 Q2	$3.18M	Buy	+57,097	New	+$2.98M	0.03%	212
2018 Q4	–	Sell	-18,494	Closed	-$1.28M	–	456
2018 Q3	$1.28M	Hold	18,494	–	–	0.01%	249
2018 Q2	$1.4M	Sell	18,494 -326,560	-95%	-$20.5M	0.01%	257
2018 Q1	$18.2M	Sell	345,054 -36,708	-10%	-$2.13M	0.14%	128
2017 Q4	$20.4M	Sell	381,762 -4,370	-1%	-$243K	0.19%	112
2017 Q3	$23M	Buy	386,132 +282,225	+272%	+$17.1M	0.24%	109
2017 Q2	$8.2M	Buy	+103,907	New	+$8.5M	0.1%	145

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jupiter Investment Management's EGRX Position: Q2 2020 in Review

Jupiter Investment Management reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 42% in Q2 2020, selling an estimated $1.76M and leaving 48,442 shares worth $2.32M. The position accounts for 0.04% of the portfolio, ranked #238.

Jupiter Investment Management first reported a position in EGRX in Q2 2017 and has held it in 11 quarters since. The position peaked at $23M in Q3 2017. 164 funds tracked by Wall St. Rank hold EGRX as of Q2 2020.

Jupiter Investment Management held 48,442 shares of Eagle Pharmaceuticals, Inc. worth $2.32M as of Q2 2020.
Jupiter Investment Management sold 35,275 Eagle Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.76M.
Eagle Pharmaceuticals, Inc. made up 0.04% of Jupiter Investment Management's portfolio in Q2 2020, its #238 holding.
Jupiter Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2017 and has held it in 11 quarters since.
Jupiter Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $23M in Q3 2017.
164 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.